SIP 1.55% $1.31 sigma pharmaceuticals limited

bulls run in 6 years already, page-2

  1. 6,148 Posts.
    lightbulb Created with Sketch. 241
    Breakout. Note underlying earnings is 5.9 cents PE of 20 is $1.20 approx.

    5 percent growth appears to be a low target.

    Aspen deal is over there maybe partners other generic. Also BOOTS dying for a strategic partner to launch in australia.

    API has a great franchise being priceline. The beauty sector exposure is a great part of the business.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.